Synopsis

Source of validity: Scientific
Rating (out of 5): 1

Monolaurin, a monoglyceride derived from lauric acid (found in coconut oil), has attracted attention for its potential antiviral properties, including activity against influenza viruses. Laboratory (in vitro) studies have demonstrated that monolaurin can disrupt the lipid envelope of certain viruses, such as influenza, leading to their inactivation. This mechanism is plausible because influenza viruses possess a lipid envelope essential for infectivity. However, while these antiviral effects are promising in cell culture studies, there is a significant gap in clinical evidence. No human clinical trials have directly evaluated the efficacy of monolaurin in the prevention or treatment of influenza.

Traditional use of monolaurin specifically for influenza is not well-documented, though coconut oil (from which monolaurin is derived) has been used in folk medicine for various ailments. The scientific rationale for monolaurin’s effect on influenza is based primarily on laboratory research rather than human studies. Thus, while there is a scientific basis for its antiviral potential, the current level of evidence supporting the use of monolaurin for influenza in humans is very weak (rated 1 out of 5). Further research, particularly clinical trials in humans, is required before monolaurin can be recommended for influenza treatment or prevention.

More about Monolaurin
More about Influenza

Other ingredients used for Influenza

Other health conditions supported by Monolaurin

Products containing Monolaurin

Designs For Health Liposomal Cat's Claw
Designs For Health Monolaurin-Avail™